Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129206) titled 'A Real-World Study on the Safety and Efficacy of Transcranial Time-Interference Stimulation (TI) in Patients with Multiple System Atrophy (Cerebellar Type)' on Aug. 1.
Study Type: Observational study
Study Design:
Single arm
Primary Sponsor: The Second Qilu Hospital of Shandong University
Condition:
Multiple system atrophy (cerebellar type)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-05
Target Sample Size: Transcranial temporal interference stimulation (TI) therapy group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.htm...